202 related articles for article (PubMed ID: 36412088)
41.
Wang Y; Kirkpatrick J; Zur Lage S; Korn SM; Neißner K; Schwalbe H; Schlundt A; Carlomagno T
Biomol NMR Assign; 2021 Oct; 15(2):287-295. PubMed ID: 33770349
[TBL] [Abstract][Full Text] [Related]
42. Optimization of 5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells.
Chen SC; Xu CT; Chang CF; Chao TY; Lin CC; Fu PW; Yu CH
Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2451-2468. PubMed ID: 36843199
[TBL] [Abstract][Full Text] [Related]
43. Structure of nonstructural protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
bioRxiv; 2020 Nov; ():. PubMed ID: 33173873
[TBL] [Abstract][Full Text] [Related]
44. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
45. The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression.
Bujanic L; Shevchuk O; von Kügelgen N; Kalinina A; Ludwik K; Koppstein D; Zerna N; Sickmann A; Chekulaeva M
RNA; 2022 May; 28(5):766-779. PubMed ID: 35232816
[TBL] [Abstract][Full Text] [Related]
46. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein.
Kamitani W; Huang C; Narayanan K; Lokugamage KG; Makino S
Nat Struct Mol Biol; 2009 Nov; 16(11):1134-40. PubMed ID: 19838190
[TBL] [Abstract][Full Text] [Related]
47. Evasion of Type I Interferon by SARS-CoV-2.
Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
[TBL] [Abstract][Full Text] [Related]
48. Structure of alphacoronavirus transmissible gastroenteritis virus nsp1 has implications for coronavirus nsp1 function and evolution.
Jansson AM
J Virol; 2013 Mar; 87(5):2949-55. PubMed ID: 23269811
[TBL] [Abstract][Full Text] [Related]
49. Biochemical and HDX Mass Spectral Characterization of the SARS-CoV-2 Nsp1 Protein.
Mishra N; Kant R; Leung DW; Gross ML; Amarasinghe GK
Biochemistry; 2023 Jun; 62(11):1744-1754. PubMed ID: 37205707
[TBL] [Abstract][Full Text] [Related]
50. Nsp1 proteins of group I and SARS coronaviruses share structural and functional similarities.
Wang Y; Shi H; Rigolet P; Wu N; Zhu L; Xi XG; Vabret A; Wang X; Wang T
Infect Genet Evol; 2010 Oct; 10(7):919-24. PubMed ID: 20609418
[TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
Min YQ; Mo Q; Wang J; Deng F; Wang H; Ning YJ
Front Microbiol; 2020; 11():587317. PubMed ID: 33133055
[TBL] [Abstract][Full Text] [Related]
52. Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase α-primase.
Kilkenny ML; Veale CE; Guppy A; Hardwick SW; Chirgadze DY; Rzechorzek NJ; Maman JD; Pellegrini L
Protein Sci; 2022 Feb; 31(2):333-344. PubMed ID: 34719824
[TBL] [Abstract][Full Text] [Related]
53. Structural and Biological Basis of Alphacoronavirus nsp1 Associated with Host Proliferation and Immune Evasion.
Shen Z; Yang Y; Yang S; Zhang G; Xiao S; Fu ZF; Peng G
Viruses; 2020 Jul; 12(8):. PubMed ID: 32731335
[TBL] [Abstract][Full Text] [Related]
54. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.
Gervasoni S; Vistoli G; Talarico C; Manelfi C; Beccari AR; Studer G; Tauriello G; Waterhouse AM; Schwede T; Pedretti A
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708196
[TBL] [Abstract][Full Text] [Related]
55. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
de Lima Menezes G; da Silva RA
J Biomol Struct Dyn; 2021 Sep; 39(15):5657-5667. PubMed ID: 32657643
[TBL] [Abstract][Full Text] [Related]
56. Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability.
Chakraborty C; Bhattacharya M; Sharma AR; Chatterjee S; Agoramoorthy G; Lee SS
Mol Biotechnol; 2024 Apr; 66(4):641-662. PubMed ID: 36463562
[TBL] [Abstract][Full Text] [Related]
57. Conformational ensemble of the NSP1 CTD in SARS-CoV-2: Perspectives from the free energy landscape.
Dutta P; Kshirsagar A; Bibekar P; Sengupta N
Biophys J; 2023 Jul; 122(14):2948-2959. PubMed ID: 36793215
[TBL] [Abstract][Full Text] [Related]
58. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition.
Yuan S; Balaji S; Lomakin IB; Xiong Y
Front Microbiol; 2021; 12():752214. PubMed ID: 34659188
[TBL] [Abstract][Full Text] [Related]
59. Parsing the role of NSP1 in SARS-CoV-2 infection.
Fisher T; Gluck A; Narayanan K; Kuroda M; Nachshon A; Hsu JC; Halfmann PJ; Yahalom-Ronen Y; Finkel Y; Schwartz M; Weiss S; Tseng CK; Israely T; Paran N; Kawaoka Y; Makino S; Stern-Ginossar N
bioRxiv; 2022 Mar; ():. PubMed ID: 35313595
[TBL] [Abstract][Full Text] [Related]
60. Universal features of Nsp1-mediated translational shutdown by coronaviruses.
Schubert K; Karousis ED; Ban I; Lapointe CP; Leibundgut M; Bäumlin E; Kummerant E; Scaiola A; Schönhut T; Ziegelmüller J; Puglisi JD; Mühlemann O; Ban N
bioRxiv; 2023 Jun; ():. PubMed ID: 37398176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
